CREB Regulates Cisplatin Resistance by Targeting TNKS and KDM6A in NSCLC cell-Derived Tumor Spheroid
International Journal of Biological Sciences · 2025
DOI: 10.7150/ijbs.109419 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2025. Verfasst von Ji Hae Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Metastasis Branch, National Cancer Center, Goyang 10408, Korea. Hauptthemen laut MEDLINE: Cisplatin, Carcinoma, Non-Small-Cell Lung, Cyclic AMP Response Element-Binding Protein, Histone Demethylases. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Metastasis Branch, National Cancer Center, Goyang 10408, Korea.
- College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Korea.
Zitieren
APA
Lee, J. H., Kwon, Y., & Yoon, K. (2025). CREB Regulates Cisplatin Resistance by Targeting TNKS and KDM6A in NSCLC cell-Derived Tumor Spheroid. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.109419
Vancouver
Lee JH, Kwon Y, Yoon K. CREB Regulates Cisplatin Resistance by Targeting TNKS and KDM6A in NSCLC cell-Derived Tumor Spheroid. International Journal of Biological Sciences. 2025. doi:10.7150/ijbs.109419
BibTeX
@article{Lee2025,
author = {Lee, Ji Hae and Kwon, Youngjoo and Yoon, Kyungsil},
title = {CREB Regulates Cisplatin Resistance by Targeting TNKS and KDM6A in NSCLC cell-Derived Tumor Spheroid},
journal = {International Journal of Biological Sciences},
year = {2025},
doi = {10.7150/ijbs.109419}
}
EUVIMED